Holen Sie sich die Stockscreener-App
90.66
1.18%
-1.08
Handel nachbörslich:
90.66
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$91.74
Offen:
$92
24-Stunden-Volumen:
3.08M
Relative Volume:
0.72
Marktkapitalisierung:
$44.08B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
164.21
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
-2.01%
1M Leistung:
+7.48%
6M Leistung:
+21.04%
1J Leistung:
+43.27%
1-Tages-Spanne:
$89.56
$92.18
1-Wochen-Bereich:
$89.56
$94.60
52-Wochen-Spanne:
$62.82
$94.60
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
90.66 | 44.60B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
231.59 | 163.86B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
21.65 | 14.87B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
48.30 | 14.54B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
53.57 | 10.38B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
BMO Capital Remains a Buy on Ventas (VTR) - The Globe and Mail
Ventas Inc. stock underperforms Friday when compared to competitors - MarketWatch
Precision Trading with Ventas Inc. (VTR) Risk Zones - Stock Traders Daily
Scotiabank Adjusts Price Target on Ventas to $93 From $88 - marketscreener.com
Sumitomo Mitsui Trust Group Inc. Has $186.12 Million Stake in Ventas, Inc. $VTR - MarketBeat
Resona Asset Management Co. Ltd. Has $24.64 Million Holdings in Ventas, Inc. $VTR - MarketBeat
Is Ventas stock outperforming the Dow? - MSN
Swedbank AB Boosts Position in Ventas, Inc. $VTR - MarketBeat
Ventas Inc. focuses on senior housing rebound as a healthcare REIT member of the S&P 500 index - ad-hoc-news.de
Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Ventas Inc focuses on senior housing recovery as US healthcare demand grows - ad-hoc-news.de
Ventas Inc. focuses on senior housing and healthcare real estate - ad-hoc-news.de
Here's what to expect from Ventas’ next earnings report - MSN
Janus Living: The Pure Play On Senior Housing Growth (NYSE:JAN) - Seeking Alpha
Ventas Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Ventas stock tracks its core healthcare portfolio - AD HOC NEWS
Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit’s REITweek 2026 Investor Conference - AOL.com
Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research - AOL.com
How Dual Russell Defensive Index Additions At Ventas (VTR) Have Changed Its Investment Story - simplywall.st
Here's What to Expect From Ventas’ Next Earnings Report - Barchart.com
Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More - Yahoo Finance
Ventas Inc. focuses on senior housing and healthcare properties as investors assess long-term cash f - ad-hoc-news.de
Barclays initiates Ventas stock coverage with Equalweight rating By Investing.com - Investing.com Canada
Barclays initiates Ventas stock coverage with Equalweight rating - Investing.com
Ventas Inc focuses on senior housing and healthcare real estate as investors weigh long-term demand - ad-hoc-news.de
Ventas Inc. focuses on senior housing and health care real estate - ad-hoc-news.de
Ventas, Inc. (NYSE:VTR) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Donald TrumpVENTAS INC UNSOLICITED Trump Trade on Mar. 23, 2026 - Quiver Quantitative
The Ventas Senior Living Communities portfolioa long-term care classic for income-focused US real - ad-hoc-news.de
Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Shares Acquired by Hsbc Holdings PLC - MarketBeat
Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend - The National Law Review
ETFs Investing in Ventas, Inc. Stocks - TradingView
Ventas Inc. focuses on senior housing and healthcare properties as a long-term real estate investmen - AD HOC NEWS
Ventas Stock Surges 14%, With A 9-Day Winning Spree - Trefis
Ventas Stock Rockets 14% With 9-Day Winning Streak - Trefis
Strs Ohio Has $65.26 Million Stock Position in Ventas, Inc. $VTR - MarketBeat
Is Ventas Inc (VTR) Overvalued After 3.2% Rally? GF Value Says O - GuruFocus
Ventas Inc | 4: Statement of changes in beneficial ownership of securities-Director Smith Maurice S - Moomoo
Ventas (VTR) director receives stock unit grant under cash compensation deferral plan - Stock Titan
[Form 4] Ventas, Inc. Insider Trading Activity - Stock Titan
Director defers fees into Ventas (NYSE: VTR) stock-based units - Stock Titan
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas (NYSE:VTR) Sets New 12-Month HighHere's What Happened - MarketBeat
CEO Debra Cafaro Leads The Way at Health Care REIT Ventas - Nareit
Ventas stock hits all-time high of 91.09 USD By Investing.com - Investing.com Nigeria
Ventas stock hits all-time high of 91.09 USD - Investing.com
Ventas Stock On Fire: Up 11% With 8-Day Winning Streak - Trefis
Ventas Inc focuses on senior housing and healthcare real estate as demand stays resilient - ad-hoc-news.de
Ventas Price Target Raised to $96.00/Share From $95.00 by Evercore ISI Group - Moomoo
Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating - marketscreener.com
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ventas Inc-Aktie (VTR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RAKOWICH WALTER C | Director |
May 14 '26 |
Sale |
90.20 |
1,152 |
103,915 |
28,349 |
0.37%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):